NCT00648713View on ClinicalTrials.gov

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Healthy
Interventions
DRUG

Terbinafine Hydrochloride Tablets 250 mg

250mg, single dose fed

DRUG

Lamisil® Tablets 250 mg

250mg, single dose fed

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648713 - Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg | Biotech Hunter | Biotech Hunter